Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells
Author:
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference32 articles.
1. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1
2. Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
3. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
4. DNA Aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier;Oncology Research;2024
2. Theranostic Lipid Nanoparticles for Renal Cell Carcinoma;Advanced Materials;2023-12-03
3. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer;Recent Patents on Anti-Cancer Drug Discovery;2023-08
4. Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook;Pharmaceutics;2023-06-23
5. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin;Pharmaceutics;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3